Parse Biosciences and bit.bio have announced a strategic alliance to develop a comprehensive transcription factor-driven cell identity map, leveraging advanced single-cell sequencing and cell programming technologies to improve predictive drug discovery and scalable therapeutic research.
Single-cell Sequencing | 29/05/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy